Literature DB >> 18024606

Diagnosis, genetics, and management of inherited bone marrow failure syndromes.

Blanche P Alter1.   

Abstract

The inherited bone marrow failure syndromes are traditionally considered to be pediatric disorders, but in fact, many of the patients now are diagnosed as adults, and many diagnosed as children now live to reach adulthood. The most common of these rare disorders include Fanconi anemia, dyskeratosis congenita, Shwachman-Diamond syndrome and amegakaryocytic thrombocytopenia, which often develop aplastic anemia and may evolve into myelodysplastic syndrome and acute myeloid leukemia; and Diamond-Blackfan anemia, severe congenital neutropenia, and thrombocytopenia absent radii, single cytopenias that rarely if ever become aplastic but have increased risks of leukemia. In addition, the first three syndromes have high risks of solid tumors: head and neck and anogenital squamous cell carcinoma in Fanconi anemia and dyskeratosis congenita, and osteogenic sarcoma in Diamond-Blackfan anemia. Diagnosis of a marrow failure syndrome requires recognition of characteristic physical abnormalities when present, and consideration of these disorders in the differential diagnosis of patients who present with "acquired" aplastic anemia, myelodysplastic syndrome, acute myeloid leukemia, or atypically early cancers of the types seen in the syndromes. Ultimate proof will come from identification of pathogenic mutations in genes associated with each syndrome.

Entities:  

Mesh:

Year:  2007        PMID: 18024606     DOI: 10.1182/asheducation-2007.1.29

Source DB:  PubMed          Journal:  Hematology Am Soc Hematol Educ Program        ISSN: 1520-4383


  62 in total

1.  Malignancies and survival patterns in the National Cancer Institute inherited bone marrow failure syndromes cohort study.

Authors:  Blanche P Alter; Neelam Giri; Sharon A Savage; June A Peters; Jennifer T Loud; Lisa Leathwood; Ann G Carr; Mark H Greene; Philip S Rosenberg
Journal:  Br J Haematol       Date:  2010-04-30       Impact factor: 6.998

2.  Genetic predisposition to myelodysplastic syndrome and acute myeloid leukemia in children and young adults.

Authors:  Daria V Babushok; Monica Bessler; Timothy S Olson
Journal:  Leuk Lymphoma       Date:  2015-12-23

3.  Discovering early molecular determinants of leukemogenesis.

Authors:  Grover C Bagby
Journal:  J Clin Invest       Date:  2008-03       Impact factor: 14.808

4.  Prevalence of FA-D2 rare complementation group of Fanconi anemia in Serbia.

Authors:  Vujić Dragana; Petrović Sandra; Lazić Emilija; Kuzmanović Miloš; Leskovac Andreja; Joksić Ivana; Mićić Dragan; Jovanović Ankica; Zečević Zeljko; Guć-Šćekić Marija; Cirković Sanja; Joksić Gordana
Journal:  Indian J Pediatr       Date:  2013-12-10       Impact factor: 1.967

5.  Necroptosis in spontaneously-mutated hematopoietic cells induces autoimmune bone marrow failure in mice.

Authors:  Junping Xin; Peter Breslin; Wei Wei; Jing Li; Rafael Gutierrez; Joseph Cannova; Allen Ni; Grace Ng; Rachel Schmidt; Haiyan Chen; Vamsi Parini; Paul C Kuo; Ameet R Kini; Patrick Stiff; Jiang Zhu; Jiwang Zhang
Journal:  Haematologica       Date:  2016-09-15       Impact factor: 9.941

6.  Diagnosis of myelodysplastic syndrome among a cohort of 119 patients with fanconi anemia: morphologic and cytogenetic characteristics.

Authors:  Adina M Cioc; John E Wagner; Margaret L MacMillan; Todd DeFor; Betsy Hirsch
Journal:  Am J Clin Pathol       Date:  2010-01       Impact factor: 2.493

7.  Mutations in the gene encoding the E2 conjugating enzyme UBE2T cause Fanconi anemia.

Authors:  Asuka Hira; Kenichi Yoshida; Koichi Sato; Yusuke Okuno; Yuichi Shiraishi; Kenichi Chiba; Hiroko Tanaka; Satoru Miyano; Akira Shimamoto; Hidetoshi Tahara; Etsuro Ito; Seiji Kojima; Hitoshi Kurumizaka; Seishi Ogawa; Minoru Takata; Hiromasa Yabe; Miharu Yabe
Journal:  Am J Hum Genet       Date:  2015-06-04       Impact factor: 11.025

Review 8.  Molecular pathogenesis and clinical management of Fanconi anemia.

Authors:  Younghoon Kee; Alan D D'Andrea
Journal:  J Clin Invest       Date:  2012-11-01       Impact factor: 14.808

Review 9.  Familial myelodysplastic syndrome/acute leukemia syndromes: a review and utility for translational investigations.

Authors:  Allison H West; Lucy A Godley; Jane E Churpek
Journal:  Ann N Y Acad Sci       Date:  2014-01-27       Impact factor: 5.691

Review 10.  Cancer in dyskeratosis congenita.

Authors:  Blanche P Alter; Neelam Giri; Sharon A Savage; Philip S Rosenberg
Journal:  Blood       Date:  2009-03-12       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.